Q1 2025 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2025-05-15 · accession 0001104659-25-049396
$87.6M
Reported value
6
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 022307102 | ALMS | Alumis Inc | $35.5M | 40.5% | 5,779,348 | Common | SOLE |
| 156944100 | CGON | CG Oncology, Inc. | $21.0M | 24.0% | 859,050 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $14.8M | 16.9% | 299,069 | Common | SOLE |
| 433000106 | HIMS | Hims & Hers Health, Inc. | $8.1M | 9.21% | 273,151 | Common | SOLE |
| 55083R104 | — | Lyell Immunopharma Inc | $4.4M | 4.99% | 8,133,047 | Common | SOLE |
| 578784100 | MAZE | Maze Therapeutics Inc | $3.8M | 4.34% | 345,191 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.